BridgeBio Oncology Therapeutics, Inc. (BBOT)

BBOT Statistics

Total Valuation

BBOT has a market cap or net worth of $1.10 billion. The enterprise value is $629.65 million.

Market Cap	1.10B
Enterprise Value	629.65M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BBOT has 79.99 million shares outstanding. The number of shares has increased by 8,840.04% in one year.

Current Share Class	79.99M
Shares Outstanding	79.99M
Shares Change (YoY)	+8,840.04%
Shares Change (QoQ)	+7,602.83%
Owned by Insiders (%)	5.66%
Owned by Institutions (%)	39.33%
Float	31.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.43
P/TBV Ratio	2.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.33, with a Debt / Equity ratio of 0.01.

Current Ratio	13.33
Quick Ratio	13.12
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-27.68%
Revenue Per Employee	n/a
Profits Per Employee	-$1.85M
Employee Count	62
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.01% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+31.01%
50-Day Moving Average	12.01
200-Day Moving Average	10.96
Relative Strength Index (RSI)	62.60
Average Volume (20 Days)	168,943

Short Selling Information

The latest short interest is 976,866, so 1.22% of the outstanding shares have been sold short.

Short Interest	976,866
Short Previous Month	815,670
Short % of Shares Out	1.22%
Short % of Float	3.14%
Short Ratio (days to cover)	2.07

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-124.29M
Pretax Income	-114.93M
Net Income	-114.93M
EBITDA	-124.04M
EBIT	-124.29M
Earnings Per Share (EPS)	-$10.31

Balance Sheet

The company has $468.29 million in cash and $2.89 million in debt, giving a net cash position of $465.40 million or $5.82 per share.

Cash & Cash Equivalents	468.29M
Total Debt	2.89M
Net Cash	465.40M
Net Cash Per Share	$5.82
Equity (Book Value)	446.70M
Book Value Per Share	5.64
Working Capital	440.30M

Cash Flow

In the last 12 months, operating cash flow was -$86.70 million and capital expenditures -$543,000, giving a free cash flow of -$87.24 million.

Operating Cash Flow	-86.70M
Capital Expenditures	-543,000
Free Cash Flow	-87.24M
FCF Per Share	-$1.09

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BBOT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8,840.04%
Shareholder Yield	-8,840.04%
Earnings Yield	-10.50%
FCF Yield	-7.97%

Analyst Forecast

The average price target for BBOT is $23.80, which is 73.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.80
Price Target Difference	73.85%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2